Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15283 | 721 | 30.1 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
465 | 3 | RENAL CELL CARCINOMA//ANGIOMYOLIPOMA//TUBEROUS SCLEROSIS | 24387 |
1854 | 2 | ANGIOMYOLIPOMA//TUBEROUS SCLEROSIS//TUBEROUS SCLEROSIS COMPLEX | 6081 |
15283 | 1 | LYMPHANGIOLEIOMYOMATOSIS//LYMPHANGIOMYOMATOSIS//PULMONARY LYMPHANGIOLEIOMYOMATOSIS | 721 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LYMPHANGIOLEIOMYOMATOSIS | authKW | 7313925 | 32% | 76% | 228 |
2 | LYMPHANGIOMYOMATOSIS | authKW | 867306 | 4% | 64% | 32 |
3 | PULMONARY LYMPHANGIOLEIOMYOMATOSIS | authKW | 778177 | 3% | 88% | 21 |
4 | MULTIFOCAL MICRONODULAR PNEUMOCYTE HYPERPLASIA | authKW | 469106 | 2% | 92% | 12 |
5 | LYMPHANGIOLEIOMYOMATOSIS LAM | authKW | 311847 | 1% | 82% | 9 |
6 | MICRONODULAR PNEUMOCYTE HYPERPLASIA | authKW | 254100 | 1% | 100% | 6 |
7 | TUBEROUS SCLEROSIS | authKW | 247748 | 10% | 8% | 75 |
8 | LYMPHANGIOMYOMA | authKW | 230569 | 1% | 78% | 7 |
9 | LAM CELLS | authKW | 211750 | 1% | 100% | 5 |
10 | MULTIFOCAL MICRONODULAR PNEUMOCYTE HYPERPLASIA MMPH | authKW | 211750 | 1% | 100% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Respiratory System | 13831 | 36% | 0% | 260 |
2 | Critical Care Medicine | 2340 | 11% | 0% | 82 |
3 | Pathology | 1267 | 12% | 0% | 89 |
4 | Medicine, General & Internal | 569 | 14% | 0% | 103 |
5 | Radiology, Nuclear Medicine & Medical Imaging | 403 | 10% | 0% | 74 |
6 | Cardiac & Cardiovascular System | 136 | 7% | 0% | 48 |
7 | Surgery | 112 | 9% | 0% | 64 |
8 | Transplantation | 74 | 2% | 0% | 18 |
9 | Cell Biology | 73 | 7% | 0% | 52 |
10 | Medical Laboratory Technology | 63 | 2% | 0% | 13 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LYMPHANGIOLEIOMYOMATOSIS | 254100 | 1% | 100% | 6 |
2 | PULM CRIT CARE MED BRANCH | 143563 | 4% | 12% | 29 |
3 | CLIN INTERSTITIAL RARE LUNG DIS | 127050 | 0% | 100% | 3 |
4 | AIRWAY BIOL INITIATPULM ALLERGY CRIT CARE | 84700 | 0% | 100% | 2 |
5 | PECAT | 84700 | 0% | 100% | 2 |
6 | RENAL TUMOUR SERV | 84700 | 0% | 100% | 2 |
7 | UNIT LUNG PHYSIOPATHOL | 84700 | 0% | 100% | 2 |
8 | THER EUT MOL MED | 79789 | 2% | 13% | 14 |
9 | PNEUMOTHORAX | 76222 | 1% | 30% | 6 |
10 | CARDIOVASC PULM BRANCH | 58317 | 3% | 7% | 19 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LYMPHATIC RESEARCH AND BIOLOGY | 13813 | 1% | 4% | 8 |
2 | CHEST | 5196 | 7% | 0% | 51 |
3 | SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES | 4167 | 1% | 1% | 8 |
4 | AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY | 2996 | 3% | 0% | 19 |
5 | RESPIRATORY MEDICINE | 2873 | 3% | 0% | 19 |
6 | AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2707 | 3% | 0% | 25 |
7 | THORAX | 1703 | 2% | 0% | 17 |
8 | LYMPHOLOGY | 1416 | 1% | 1% | 6 |
9 | HORMONES & CANCER | 1172 | 0% | 1% | 2 |
10 | EUROPEAN RESPIRATORY JOURNAL | 1172 | 2% | 0% | 16 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CHEBIB, N , KHOUATRA, C , LAZOR, R , ARCHER, F , LEROUX, C , GAMONDES, D , THIVOLET-BEJUI, F , CORDIER, JF , COTTIN, V , (2016) PULMONARY LYMPHANGIOLEIOMYOMATOSIS: FROM PATHOGENESIS TO MANAGEMENT.REVUE DES MALADIES RESPIRATOIRES. VOL. 33. ISSUE 8. P. 718 -734 | 95 | 74% | 0 |
2 | MOSS, AMTDJ , (2015) CLINICAL FEATURES, EPIDEMIOLOGY, AND THERAPY OF LYMPHANGIOLEIOMYOMATOSIS.CLINICAL EPIDEMIOLOGY. VOL. 7. ISSUE . P. 249 -257 | 72 | 86% | 3 |
3 | TAVEIRA-DASILVA, AM , MOSS, J , (2016) EPIDEMIOLOGY, PATHOGENESIS AND DIAGNOSIS OF LYMPHANGIOLEIOMYOMATOSIS.EXPERT OPINION ON ORPHAN DRUGS. VOL. 4. ISSUE 4. P. 369 -378 | 73 | 83% | 0 |
4 | HARARI, S , TORRE, O , CASSANDRO, R , MOSS, J , (2015) THE CHANGING FACE OF A RARE DISEASE: LYMPHANGIOLEIOMYOMATOSIS.EUROPEAN RESPIRATORY JOURNAL. VOL. 46. ISSUE 5. P. 1471 -1485 | 87 | 70% | 1 |
5 | MCCORMACK, FX , GUPTA, N , FINLAY, GR , YOUNG, LR , TAVEIRA-DASILVA, AM , GLASGOW, CG , STEAGALL, WK , JOHNSON, SR , SAHN, SA , RYU, JH , ET AL (2016) OFFICIAL AMERICAN THORACIC SOCIETY/JAPANESE RESPIRATORY SOCIETY CLINICAL PRACTICE GUIDELINES: LYMPHANGIOLEIOMYOMATOSIS DIAGNOSIS AND MANAGEMENT.AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. VOL. 194. ISSUE 6. P. 748 -761 | 67 | 84% | 0 |
6 | JOHNSON, SR , CORDIER, JF , LAZOR, R , COTTIN, V , COSTABEL, U , HARARI, S , REYNAUD-GAUBERT, M , BOEHLER, A , BRAUNER, M , POPPER, H , ET AL (2010) EUROPEAN RESPIRATORY SOCIETY GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF LYMPHANGIOLEIOMYOMATOSIS.EUROPEAN RESPIRATORY JOURNAL. VOL. 35. ISSUE 1. P. 14 -26 | 65 | 72% | 126 |
7 | JOHNSON, SR , TAVEIRA-DASILVA, AM , MOSS, J , (2016) LYMPHANGIOLEIOMYOMATOSIS.CLINICS IN CHEST MEDICINE. VOL. 37. ISSUE 3. P. 389 -+ | 70 | 76% | 0 |
8 | URBAN, T , (2007) PULMONARY LYMPHANGIOLEIOMYOMATOSIS WITH OR WITHOUT TUBEROUS SCLEROSIS.REVUE DES MALADIES RESPIRATOIRES. VOL. 24. ISSUE 6. P. 725 -740 | 84 | 71% | 3 |
9 | TAVEIRA-DASILVA, AM , PACHECO-RODRIGUEZ, G , MOSS, J , (2010) THE NATURAL HISTORY OF LYMPHANGIOLEIOMYOMATOSIS: MARKERS OF SEVERITY, RATE OF PROGRESSION AND PROGNOSIS.LYMPHATIC RESEARCH AND BIOLOGY. VOL. 8. ISSUE 1. P. 9 -19 | 64 | 80% | 27 |
10 | SULLIVAN, EJ , (1998) LYMPHANGIOLEIOMYOMATOSIS - A REVIEW.CHEST. VOL. 114. ISSUE 6. P. 1689 -1703 | 73 | 90% | 130 |
Classes with closest relation at Level 1 |